Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-22

FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Abiraterone acetate from Apotex Corp. (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)